Healthcare Services

Global Amniotic Membrane Market Global Report 2026 Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Amniotic Membrane Market Projected To Become By 2030 Based On Its 2026 Valuation?

The amniotic membrane market has experienced substantial expansion in recent times. This market is projected to expand from $1.88 billion in 2025 to $2.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. Historically, this growth was driven by several factors, including the increased scope of regenerative medicine research, the rising demand for surgical wound care, its integration into ophthalmology, the accessibility of advanced tissue preservation techniques, and the proliferation of hospital-administered biologic therapies.

The amniotic membrane market is projected for significant expansion over the coming years, with its size expected to reach $3.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This anticipated growth during the forecast period is primarily fueled by an increasing demand for advanced wound healing solutions, a rising adoption in minimally invasive surgical procedures, the expansion of outpatient surgical procedures, a growing focus on biologic-based therapies, and increasing regulatory clarity for tissue-based products. Key trends identified for the forecast period encompass the expanding use of amniotic membranes in regenerative therapies, their increasing utilization in ophthalmic procedures, broadening applications within wound care, a surging demand for cryopreserved products, and an enhanced emphasis on biologic safety standards.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8830&type=smp

What Primary Drivers Are Shaping The Development Of The Amniotic Membrane Market?

The expansion of transplant operations is anticipated to boost the amniotic membrane market in the future. Transplantation, which involves the surgical transfer of tissues or organs from a donor to a recipient, frequently employs amniotic membranes in surgical and reconstructive procedures to aid tissue repair and recovery. The surge in transplant procedures is attributed to factors like heightened organ donation awareness, advancements in surgical techniques, and improved processes for donor-recipient matching. Amniotic membrane allografts contribute to post-transplant healing by supplying a biologically active extracellular matrix and regulatory proteins that encourage tissue regeneration. As an illustration, in January 2024, data from the Organ Procurement and Transplantation Network (OPTN), a US-based entity managing the national organ transplant system, revealed that the United States achieved 46,632 total organ transplants in 2023, marking an 8.7 percent increase from 2022, and 41,119 deceased-donor transplants in 2024, representing a further 3.6 percent rise over 2023, driven by consistent annual increases. Consequently, the escalating transplant activity is propelling the growth of the amniotic membrane market. The growing occurrence of chronic diseases is expected to stimulate the expansion of the amniotic membrane market moving forward. A chronic disease is defined as an illness persisting for three months or longer that can worsen over time. The distinct characteristics of amniotic membranes, such as their anti-inflammatory and regenerative capabilities, make them invaluable for managing chronic conditions, mitigating complications, and addressing tissue damage. The extensive applicability of amniotic membranes allows their use across various medical fields, thereby meeting the demand for effective therapeutic interventions related to chronic diseases. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, projected that new cancer cases would exceed 35 million by 2050, signifying a 77% increase compared to the estimated 20 million cases in 2022. Thus, the increasing prevalence of chronic diseases is driving the growth of the amniotic membrane market.

What Segment Groups Are Identified Within The Amniotic Membrane Market?

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

What Trends Are Advancing Progress In The Amniotic Membrane Market?

Companies operating in the amniotic membrane market are prioritizing the development of advanced allografts to elevate patient care and clinical outcomes. Amniotic membrane allografts are tissues derived from the placenta’s innermost layer, employed in treating ocular and surgical wounds by supplying a natural extracellular matrix and growth factors to foster healing. For instance, in December 2024, BioTissue, a US-based biotechnology company, launched CAM360 AmnioGraft (CAM360 AG), a ringless, shelf-stable cryopreserved amniotic membrane intended for the treatment of mild to moderate dry eye and early-stage neurotrophic keratitis. This product offers eye care professionals versatile application options, including its use under a bandage contact lens or with a collagen shield, and facilitates rapid symptom relief within 48 hours. CAM360 AG expands treatment choices while also simplifying inventory management for clinics. Therefore, innovations such as CAM360 AG are significantly driving growth in the amniotic membrane market.

Which Companies Hold Significant Positions In The Amniotic Membrane Market?

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Read the full amniotic membrane market report here:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

How Does The Amniotic Membrane Market Perform Across Major Global Regions?

North America was the largest region in the amniotic membrane market share in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Amniotic Membrane Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8830&type=smp

Browse Through More Reports Similar to the Global Amniotic Membrane Market 2026, By The Business Research Company

amniotic products global market report

https://www.thebusinessresearchcompany.com/report/amniotic-products-global-market-report

specialty breathable membranes global market report

https://www.thebusinessresearchcompany.com/report/specialty-breathable-membranes-global-market-report

breathable membranes global market report

https://www.thebusinessresearchcompany.com/report/breathable-membranes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795